Search

Your search keyword '"Alison R. Yung"' showing total 369 results

Search Constraints

Start Over You searched for: Author "Alison R. Yung" Remove constraint Author: "Alison R. Yung" Topic psychiatry and mental health Remove constraint Topic: psychiatry and mental health
369 results on '"Alison R. Yung"'

Search Results

1. The role of metformin as a treatment for neuropsychiatric illness

2. Proportion and characteristics of young people in a first-episode psychosis clinic who first attended an at-risk mental state service or other specialist youth mental health service

Catalog

Books, media, physical & digital resources

3. Role of Diet in Depression in Young People: Recommendations for Implementation in Practice

4. Clinical and cost-effectiveness of social recovery therapy for the prevention and treatment of long-term social disability among young people with emerging severe mental illness (PRODIGY): randomised controlled trial

7. Investigation of structural brain correlates of neurological soft signs in individuals at ultra-high risk for psychosis

8. Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample

9. Cannabidiol for at risk for psychosis youth: A randomized controlled trial

10. Intervention strategies for ultra-high risk for psychosis: Progress in delaying the onset and reducing the impact of first-episode psychosis

11. Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people

12. Supplementation with the omega-3 long chain polyunsaturated fatty acids: Changes in the concentrations of omega-3 index, fatty acids and molecular phospholipids of people at ultra high risk of developing psychosis

13. Early persistence of <scp>psychotic‐like</scp> experiences in a community sample of adolescents

14. Transcending false dichotomies and diagnostic silos to reduce disease burden in mental disorders

15. Cognitive functioning in ultra-high risk for psychosis individuals with and without depression: Secondary analysis of findings from the NEURAPRO randomized clinical trial

16. Terminology and assessment tools of psychosis: A systematic narrative review

17. Childhood trauma is prevalent and associated with co-occurring depression, anxiety, mania and psychosis in young people attending Australian youth mental health services

19. Twelve-month cognitive trajectories in individuals at ultra-high risk for psychosis : a latent class analysis

20. The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia

21. Greater preference for eveningness is associated with negative symptoms in an ultra-high risk for psychosis sample

22. Intelligence trajectories in individuals at ultra-high risk for psychosis: An 8-year longitudinal analysis

23. The value of early intervention in creating the new mental health system: Response to Allison et al

24. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes

25. Handgrip Strength Is Associated With Hippocampal Volume and White Matter Hyperintensities in Major Depression and Healthy Controls: A UK Biobank Study

26. The reality of at risk mental state services: a response to recent criticisms

27. Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis

28. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis:An ENIGMA Working Group Mega-analysis

29. The association between migrant status and transition in an ultra-high risk for psychosis population

30. A review of economic evaluations of health care for people at risk of psychosis and for first-episode psychosis

31. Prevalence of major cardiovascular disease events among people diagnosed with schizophrenia who have sleep disturbance, sedentary behavior or muscular weakness

32. Patients', carers' and clinicians' attitudes towards alternative terms to describe the at-risk for psychosis state

33. Perceived stress and psychosis: The effect of perceived stress on psychotic‐like experiences in a community sample of adolescents

34. Transdiagnostic clinical staging in youth mental health: a first international consensus statement

35. Evidence for preventive treatments in young patients at clinical high risk of psychosis: the need for context

36. Commentary: Preventive Treatments for Psychosis: Umbrella Review (Just the Evidence)

37. Prediction of clinical outcomes beyond psychosis in the ultra-high risk for psychosis population

38. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo

39. Exploring functional impairment in young people at ultra-high risk for psychosis: A qualitative study

40. Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis

41. Examining the feasibility, acceptability, validity and reliability of physical activity, sedentary behaviour and sleep measures in people with schizophrenia

42. Perceptual abnormalities in an ultra‐high risk for psychosis population relationship to trauma and co‐morbid disorder

43. Metacognitive beliefs in the at-risk mental state: A systematic review and meta-analysis

44. T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL

45. Global research priorities for youth mental health

46. Does cortical brain morphology act as a mediator between childhood trauma and transition to psychosis in young individuals at ultra-high risk?

47. Evidence-based guidelines for the pharmacological treatment of schizophrenia:Updated recommendations from the British Association for Psychopharmacology

48. Distress related to psychotic symptoms in individuals at high risk of psychosis

49. Impaired olfactory ability associated with larger left hippocampus and rectus volumes at earliest stages of schizophrenia: A sign of neuroinflammation?

50. Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?